Despite the immature state of stem cell medicine, patients are seeking and accessing putative
stem cell therapies in an "early market" in which direct-to-consumer advertising via the …

Background: Greater awareness of sleep-disordered breathing and rising obesity rates have
fueled demand for sleep studies. Sleep testing using level 3 portable devices may expedite …

Chronic obstructive pulmonary disease (COPD) is a rapidly growing public health problem
in the United States and elsewhere. Although direct costs of COPD are well documented, the …

As tensions between payers, responsible for ensuring prudent and principled use of scarce
resources, and both providers and patients, who legitimately want access to technologies …

Objectives To assess the feasibility of using a citizens’ jury to elicit public values on health
technologies and to develop criteria for setting priorities for health technology assessment (…

Background The rate of development of new orphan drugs continues to grow. As a result,
reimbursing orphan drugs on an exceptional basis is increasingly difficult to sustain from a …

Health technology assessment (HTA) has become an integral part of decision-making on
the coverage of new health technologies in most health systems in the developed world. In …

For over 40 years, Canada has had a publicly funded, national health-care system
designed to ensure residents receive “reasonable access” to “medically necessary” health-care …

There is an inevitable tension between robust reimbursement processes and providing speedy
access to new and novel technologies, given uncertainties about key pieces of evidence …

All healthcare systems routinely make resource allocation decisions that trade off potential
health gains to different patient populations. However, when such trade-offs relate to the …